Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2645 | Tofacitinib | 0.3 | uM | 2 | MIP-1B | 53.0 | 55 | ||||
N2645 | 2 | MIP-1B | 53.0 | 77 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 2 | MIP-1B | 57.0 | 67 | ||||
RA2708 | 2 | MIP-1B | 59.5 | 48 | |||||||
0 | MIP-1B | 63.0 | 47 | ||||||||
0 | MIP-1B | 70.0 | 59 | ||||||||
0 | MIP-1B | 64.0 | 53 | ||||||||
0 | MIP-1B | 67.0 | 67 | ||||||||
0 | MIP-1B | 65.5 | 64 | ||||||||
0 | MIP-1B | 65.0 | 51 | ||||||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | MIP-1B | 61.5 | 70 | ||||
RA1869 | IKK16 | 2.0 | uM | 3 | MIP-1B | 56.5 | 80 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 3 | MIP-1B | 62.0 | 82 | ||||
N2759 | IKK16 | 2.0 | uM | 3 | MIP-1B | 62.0 | 81 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 3 | MIP-1B | 58.0 | 89 | ||||
RA1931 | IKK16 | 2.0 | uM | 3 | MIP-1B | 60.0 | 71 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 3 | MIP-1B | 55.0 | 91 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | MIP-1B | 57.0 | 69 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 3 | MIP-1B | 59.0 | 63 | ||||
RA1869 | 3 | MIP-1B | 52.0 | 79 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 3 | MIP-1B | 61.5 | 74 | ||||
N2759 | 3 | MIP-1B | 60.0 | 86 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 3 | MIP-1B | 57.0 | 69 | ||||
RA1931 | 3 | MIP-1B | 57.0 | 65 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 3 | MIP-1B | 64.0 | 78 |